tiprankstipranks
Trending News
More News >
Iovance Biotherapeutics Inc (DE:2LB)
FRANKFURT:2LB
Germany Market

Iovance Biotherapeutics (2LB) Income Statement

Compare
17 Followers

Iovance Biotherapeutics Income Statement

Last quarter (Q4 2025), Iovance Biotherapeutics's total revenue was $86.77M, an increase of 17.74% from the same quarter last year. In Q4, Iovance Biotherapeutics's net income was $-71.90M. See Iovance Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 263.50M$ 164.07M$ 1.19M$ 0.00$ 0.00
Gross Profit
$ 256.22M$ 40.08M$ -9.57M$ 0.00$ 0.00
Operating Expenses
$ 659.57M$ 435.35M$ 450.99M$ 398.88M$ 342.70M
Depreciation and Amortization
$ 35.94M$ 43.61M$ 33.13M$ 21.14M$ 13.98M
EBITDA
$ -357.11M$ -351.67M$ -427.43M$ -377.74M$ -328.72M
Operating Income
$ -403.36M$ -395.28M$ -460.56M$ -398.88M$ -342.70M
Other Income/Expenses
$ 10.31M$ 20.27M$ 13.04M$ 2.98M$ 451.00K
Pretax Income
$ -393.05M$ -375.00M$ -447.52M$ -395.89M$ -342.25M
Net Income
$ -390.98M$ -372.18M$ -444.04M$ -395.89M$ -342.25M
Per Share Metrics
Basic EPS
$ -1.09$ -1.28$ -1.89$ -2.49$ -2.23
Diluted EPS
$ -1.09$ -1.28$ -1.89$ -2.49$ -2.23
Weighted Average Shares Outstanding
357.35M 289.88M 235.13M 159.26M 153.41M
Weighted Average Shares Outstanding (Diluted)
357.35M 289.88M 235.13M 159.26M 153.41M
Currency in USD

Iovance Biotherapeutics Earnings and Revenue History